205 related articles for article (PubMed ID: 18983337)
21. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
Bevilacqua M; Dominguez LJ; Barbagallo M
J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
[TBL] [Abstract][Full Text] [Related]
22. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function.
Klaus JR; Hurwitz BE; Llabre MM; Skyler JS; Goldberg RB; Marks JB; Bilsker MS; Schneiderman N
J Cardiometab Syndr; 2009; 4(2):63-71. PubMed ID: 19614791
[TBL] [Abstract][Full Text] [Related]
23. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
[TBL] [Abstract][Full Text] [Related]
24. Detecting microalbuminuria and taking action in the cardiometabolic syndrome and type 2 diabetes mellitus.
Hayden MR; Kolb L; Chowdbury N; Karuparthi PR; Khanna R; Sowers JR
Mo Med; 2006; 103(5):533-8. PubMed ID: 17133759
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance and nitric oxide and associated renal injury: innocent bystanders or accessories to the crime?
Ahmed MH
N Z Med J; 2006 Aug; 119(1239):U2112. PubMed ID: 16912729
[No Abstract] [Full Text] [Related]
26. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
27. Hyperuricemia, gout and the metabolic syndrome.
Puig JG; Martínez MA
Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
[TBL] [Abstract][Full Text] [Related]
28. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
29. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis and the metabolic syndrome.
Gottlieb AB; Dann F; Menter A
J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.
Fortuño A; Bidegain J; San José G; Robador PA; Landecho MF; Beloqui O; Díez J; Zalba G
J Hypertens; 2009 Jul; 27(7):1420-30. PubMed ID: 19357530
[TBL] [Abstract][Full Text] [Related]
33. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
34. Arterial stiffness and insulin resistance.
Westerbacka J; Yki-Järvinen H
Semin Vasc Med; 2002 May; 2(2):157-64. PubMed ID: 16222607
[TBL] [Abstract][Full Text] [Related]
35. [Insulin resistance and chronic kidney disease].
Chauveau P; Rigalleau V; Aparicio M
Nephrol Ther; 2008 Dec; 4(7):568-74. PubMed ID: 18514051
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk and the urological patient.
Kirby M; Kirby R
BJU Int; 2009 Nov; 104(9):1185-6. PubMed ID: 19583722
[No Abstract] [Full Text] [Related]
37. Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors.
Chang YC; Lin JW; Wang LC; Chen HM; Hwang JJ; Chuang LM
Eye (Lond); 2010 Jun; 24(6):1037-43. PubMed ID: 19816514
[TBL] [Abstract][Full Text] [Related]
38. The metabolic syndrome as a risk factor for venous and arterial thrombosis.
Dentali F; Squizzato A; Ageno W
Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035
[TBL] [Abstract][Full Text] [Related]
39. State of the heart in the metabolic syndrome.
de Simone G
Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):239-41. PubMed ID: 16054546
[No Abstract] [Full Text] [Related]
40. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
